Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

ganglidiomab

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Vaccination with proteins mimicking GD2 that is highly expressed on neuroblastoma (NB) cells is a promising strategy in treatment… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Human/mouse chimeric monoclonal antibody (mAb) ch14.18/CHO is directed against disialoganglioside GD2. Activity and efficacy of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
2013
2013
PurposeImmunotherapy targeting disialoganglioside GD2 emerges as an important treatment option for neuroblastoma, a pediatric… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2013
2013
Human/mouse chimeric monoclonal antibody (mAb) ch14.18 is directed against disialoganglioside GD2 and has demonstrated activity… Expand